MGUS
9
4
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study
Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA Fragmentomics
Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment
European Myeloma Network (EMN) Sample Project
PROFAST Intervention in Precursor Multiple Myeloma
A Prospective Long-term Observational Study in Patients With Monoclonal Gammopathy of Undetermined Significance
Intestinal Flora and Immunity in Monoclonal Gammopathy Patients
Biology and Genetics of Smouldering Myeloma
Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients